Symbolism of the US battlefield cross: how boots, rifles, and helmets reinforce masculinity - Dundes L.
This paper explores the unconscious symbolism of the battlefield cross memorial, which is comprised of combat boots and a rifle, often with dog tags attached, topped by a helmet. While the memorial's manifest function is to provide solace, build solidarity...
Source: SafetyLit - May 22, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Famous great white shark Ironbound spotted off U.S. coast again
A famous great white shark known as Ironbound has been spotted swimming of the U.S. coast again. The huge shark, which measures 12 foot, 4 inches, and weighs 1,189 pounds, was tracked swimming off the coast of South Carolina on May 18 by ocean research organization OCEARCH. OCEARCH tags sharks to…#ironbound #southcarolina #ocearch #atlantic #eastcoast #gavinnaylor #southflorida #carolinas #florida #breton
Source: Reuters: Health - May 22, 2023 Category: Consumer Health News Source Type: news

$25K Up for Grabs as Huobi Launches Contest for Elon Musk-Supported Dogecoin (DOGE), Others
Top crypto exchange Huobi has announced a trading contest, which it tags "Elon-Promoted Meme Tokens Trading Contests." The cryptocurrencies at the center of the trading contest are Dogecoin (DOGE), Pepe (PEPE), Milady Meme Coin (LADYS), Floki (FLOKI) and ArbDoge AI (AIDOGE). Winners in the contest…#dogecoin #doge #miladymemecoin #arbdogeai #aidoge #usdt #tesla #elonmusk #mcdonaldhappymeal #milady
Source: Reuters: Health - May 20, 2023 Category: Consumer Health News Source Type: news

FDA accepts application for Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
Acceptance based on two phase III studies that demonstrated early and sustained vision improvement with Vabysmo, meeting primary endpoint of non-inferiority compared to afliberceptApplication was further supported by data showing Vabysmo achieved rapid and robust drying of retinal fluidIf approved, RVO would be the third indication for Vabysmo in addition to neovascular or ‘wet’ age-related macular degeneration (nAMD) and diabetic macular edema (DME)Vabysmo is currently approved in 60 countries to treat nAMD and DME, with nearly one million doses distributed globallyBasel, 9 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY...
Source: Roche Investor Update - May 9, 2023 Category: Pharmaceuticals Source Type: news

Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
HORSHAM, Pa., May 2, 2023 – Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc. (CBMG) to develop, manufacture and commercialize next-generation chimeric antigen receptor (CAR) T-cell therapies for the treatment of B-cell malignancies. These investigational CD20-directed autologous CAR-Ts have demonstrated promising overall and complete response rates in Phase 1 studies in patients with relapsed/refractory non-Hodgkin’s lymphoma (NHL) in China, with the m...
Source: Johnson and Johnson - May 2, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Janssen Reports First Results from Phase 2 SunRISe-1 Study of TAR-200 and Anti- PD-1 Antibody Cetrelimab in Patients with Bacillus Calmette-Gu érin-Unresponsive Non-Muscle-Invasive Bladder Cancer
CHICAGO, April 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from the open-label Phase 2 SunRISe-1 study evaluating the efficacy and safety of TAR-200 monotherapy (a novel investigational intravesical drug delivery system) and cetrelimab monotherapy (an investigational anti-PD-1 monoclonal antibody administered intravenously) in patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC), who are ineligible for, or decline, radical cystectomy. The study demonstrated that 72.7 percent of patients treated wit...
Source: Johnson and Johnson - April 30, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

The Best Luxury Mother ' s Day Gifts That Still Cost Under $50
When you think of luxury, your mind may immediately go to items with one (or maybe even two) commas in their price tags. But lavish living doesn’t have to be expensive. Allow us to introduce you to little luxuries, which are small items that add a dash of pleasure and comfort to everyday living ―…#huffpost #huffpostshopping
Source: Reuters: Health - April 29, 2023 Category: Consumer Health News Source Type: news

Bed Bath & Beyond Shoppers Hurry to Use Their Stacks of Coupons for the Last Time
Many Bed Bath & Beyond Inc. shoppers are saying goodbye to the retail giant the only way they know how: Leaving with bags of stuff marked down by 20% off coupons. Shoppers flocked to the chain’s last Manhattan store this week to peruse aisles full of red sales tags. Most of them said they came…#manhattan #bedbathbeyond
Source: Reuters: Health - April 26, 2023 Category: Consumer Health News Source Type: news

New Vabysmo data suggest greater retinal drying versus aflibercept in nAMD and DME
Post-hoc analyses from four phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in neovascular or ‘wet’ age-related macular degeneration (nAMD) and diabetic macular edema (DME)More Vabysmo patients with nAMD had absence of retinal fluid at 12 weeks in a post-hoc analysis from the phase III TENAYA and LUCERNE studiesDME patients treated with Vabysmo had less blood vessel leakage in the macula at 16 weeks in a post-hoc analysis from the phase III YOSEMITE and RHINE studiesBasel, 25 April 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that post-hoc data indicate treatment with Va...
Source: Roche Investor Update - April 25, 2023 Category: Pharmaceuticals Source Type: news

How Equity Market Sectors are Evolving
https://www.cmegroup.com/openmarkets/equity-index/2023/How-Equity-Market-Sectors-are-Evolving.html?utm_medium=rss&utm_campaign=distribution
Source: Reuters: Health - April 17, 2023 Category: Consumer Health News Source Type: news

' Quiet luxury ' : No flash, no logos, but big-time style
They're the biggest of brands. But with no logos. And that's the whole point. → The "King Of Quants" sees 10X potential... (From Investor Place Media) Call it stealth wealth, or quiet luxury. For the rich and those who aspire, logo-free fashion with outsized price tags is having a moment — at…#kingofquants #thinkhollywood #gwynethpaltrow #prada #celine #utah #robertburke #cuehbo #michellematland #kardashians
Source: Reuters: Health - April 14, 2023 Category: Consumer Health News Source Type: news

Roche data highlights strength of ophthalmology portfolio and commitment to advancing eye care at ARVO 2023
Vabysmo data suggest rapid and robust drying of retinal fluid in patients withneovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaReal-world studies ofVabysmo demonstrate ability to extend treatment intervals in the first four months while maintaining visual acuityClinical data on an investigational anti-interleukin-6 treatment inuveitic macular edema will be presented for the first timeBasel, 13 April 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data for its approved and investigational medicines will be highlighted in 30 abstracts at the 2023 Association for Research ...
Source: Roche Media News - April 13, 2023 Category: Pharmaceuticals Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20